{"id":120127,"date":"2021-08-19T15:13:08","date_gmt":"2021-08-19T15:13:08","guid":{"rendered":"https:\/\/fin2me.com\/?p=120127"},"modified":"2021-08-19T15:13:08","modified_gmt":"2021-08-19T15:13:08","slug":"cathie-woods-ark-invest-sells-over-40000-shares-of-baidu","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/cathie-woods-ark-invest-sells-over-40000-shares-of-baidu\/","title":{"rendered":"Cathie Wood’s ARK Invest Sells Over 40,000 Shares of Baidu"},"content":{"rendered":"
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 40,000 shares of Baidu Inc. (NASDAQ: BIDU) on Wednesday, as the share price of this fund traded relatively flat in the day\u2019s session. The fund\u2019s share price has greatly improved over the past year.<\/p>\n
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKK) sold 44,810 shares of Baidu. At Wednesday\u2019s closing price, this would have valued this sale at roughly $6.4 million. This is only a small fraction of the total holdings. This fund is up 43% over the past 52 weeks.<\/p>\n
Here is a quick look at all the other sales that took place across all ARK ETFs:<\/p>\n
Fund<\/th>\n | Ticker<\/th>\n | Company<\/th>\n | Shares<\/th>\n<\/tr>\n<\/thead>\n |
---|---|---|---|
ARKF<\/td>\n | 1833HK<\/td>\n | Ping An Healthcare and Technology<\/td>\n | 451,500<\/td>\n<\/tr>\n |
ARKG<\/td>\n | TXG<\/td>\n | 10X Genomics<\/td>\n | 48,490<\/td>\n<\/tr>\n |
ARKG<\/td>\n | SRPT<\/td>\n | Sarepta Therapeutics<\/td>\n | 73,604<\/td>\n<\/tr>\n |
ARKG<\/td>\n | RHHBY<\/td>\n | Roche<\/td>\n | 140,600<\/td>\n<\/tr>\n |
ARKG<\/td>\n | REGN<\/td>\n | Regeneron Pharmaceuticals<\/td>\n | 19,393<\/td>\n<\/tr>\n |
ARKG<\/td>\n | PSTI<\/td>\n | Pluristem Therapeutics<\/td>\n | 9,907<\/td>\n<\/tr>\n |
ARKG<\/td>\n | NVS<\/td>\n | Novartis<\/td>\n | 52,621<\/td>\n<\/tr>\n |
ARKK<\/td>\n | MCRB<\/td>\n | Seres Therapeutics<\/td>\n | 3,968<\/td>\n<\/tr>\n |
ARKK<\/td>\n | SQ<\/td>\n | Square<\/td>\n | 1,887<\/td>\n<\/tr>\n |
ARKK<\/td>\n | DOCU<\/td>\n | Docusign<\/td>\n | 57,133<\/td>\n<\/tr>\n |
ARKK<\/td>\n | PRLB<\/td>\n | Proto Labs<\/td>\n | 700<\/td>\n<\/tr>\n |
ARKK<\/td>\n | NTDOY<\/td>\n | Nintendo<\/td>\n | 77,571<\/td>\n<\/tr>\n |
ARKK<\/td>\n | NSTG<\/td>\n | Nanostring Technologies<\/td>\n | 12,355<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | XONE<\/td>\n | Exone<\/td>\n | 82,472<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | BIDU<\/td>\n | Baidu<\/td>\n | 44,810<\/td>\n<\/tr>\n |
ARKW<\/td>\n | SHOP<\/td>\n | Shopify<\/td>\n | 5,400<\/td>\n<\/tr>\n |
ARKX<\/td>\n | AIRFP<\/td>\n | Airbus<\/td>\n | 22,114<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \nCatherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24\/7 Wall St.<\/em><\/p>\n \t\t\t<\/p>\n \t\t\t\tALSO READ: A Big Correction May Be Coming: Goldman Sachs Says Buy High-Dividend REITs Now \t\t\t\t |